Skip to main content
Molecular Genetics and Metabolism Reports logoLink to Molecular Genetics and Metabolism Reports
letter
. 2016 Dec 11;10:18–19. doi: 10.1016/j.ymgmr.2016.12.002

Phenotypic heterogeneity of MELAS☆☆

Josef Finsterer a,1,, Sinda Zarrouk-Mahjoub b,1
PMCID: PMC5153459  PMID: 27995078

Letter to the Editor

With interest we read the article by Dvorakova et al. about 50 Czech patients carrying the m.3243A > G mutation [1]. It raises questions and concerns.

Since MELAS is a progressive disease, we should be informed about the long-term follow-up findings in the 50 mutation carriers. How many of the 17 patients without clinical manifestations at inclusion developed MELAS during follow-up?

How many of the patients had a family history positive for MELAS, and in how many families were first-degree relatives tested for the m.3243A > G mutation?

Altogether, 42% of the patients had seizures [1]. How many of the seizures in these patients occurred prior to a stroke-like episode (SLE), during a SLE, or were unrelated to SLEs? [2]

Which were the cardiovascular risk factors among those with ischemic strokes? Was ischemic stroke related to SLE's or independent of it?

Which was the cause of rhabdomyolysis in the two reported patients? [1] Was it a previous seizures, alcohol consumption, a drug, or other causes? Did those with rhabdomyolysis also have myopathy?

How many of those with psychiatric disturbances had abnormalities on cerebral MRI or EEG? How many of those with psychiatric disease had SLEs or seizures?

Since a number of drugs may be mitochondrion-toxic, in particular antiepileptic drugs (AEDs) (phenytoin, valproate, carbamazepine, phenobarbital), we should be informed how many patients were regularly taking AEDs or other drugs.

How many of the 50 patients had undergone a lactate stress test? [3] How many of those with normal serum lactate levels had an abnormal lactate stress test?

Recently it has been shown that also the lungs may be affected by a mitochondrial defect (Table 1) [4]. How many of the patients had lung disease, attributable to the m.3243A > G mutation?

Table 1.

Pulmonary involvement in mitochondrial disorders.

Pulmonary disease Mutated gene Reference
Hyaline membrane disease LARS2 [5]
Pulmonary hypertension LARS2 [5]
Pulmonary hypertension TMEM70 [6]
Interstitial fibrosis NDUFAF6 [4]
Acute lung hemorrhage nr [7]
Restrictive pulmonary insufficiency tRNA(Leu) [8], [9]
Asthma tRNA(Leu) [10]
Poor ventilator response to hypercapnia nr [11]
Obstructive sleep apnea nr [12]

Nr: not reported.

Overall, this interesting study would profit from provision of information about the progression of the disease, family history, drug history, and diagnostic work-up.

Footnotes

There are no conflicts of interest

☆☆

No funding was received

References

  • 1.Dvorakova V., Kolarova H., Magner M., Tesarova M., Hansikova H., Zeman J., Honzik T. The phenotypic spectrum of fifty Czech m.3243A > G carriers. Mol. Genet. Metab. 2016;118:288–295. doi: 10.1016/j.ymgme.2016.06.003. [DOI] [PubMed] [Google Scholar]
  • 2.Finsterer J., Wakil S.M. Stroke-like episodes, peri-episodic seizures, and MELAS mutations. Eur. J. Paediatr. Neurol. 2016;20:824–829. doi: 10.1016/j.ejpn.2016.08.002. [DOI] [PubMed] [Google Scholar]
  • 3.Finsterer J., Milvay E. Stress lactate in mitochondrial myopathy under constant, unadjusted workload. Eur. J. Neurol. 2004;11:811–816. doi: 10.1111/j.1468-1331.2004.00859.x. [DOI] [PubMed] [Google Scholar]
  • 4.Hartmannová H., Piherová L., Tauchmannová K., Kidd K., Acott P.D., Crocker J.F., Oussedik Y., Mallet M., Hodaňová K., Stránecký V., Přistoupilová A., Barešová V., Jedličková I., Živná M., Sovová J., Hůlková H., Robins V., Vrbacký M., Pecina P., Kaplanová V., Houštěk J., Mráček T., Thibeault Y., Bleyer A.J., Kmoch S. Acadian variant of Fanconi syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6. Hum. Mol. Genet. 2016 doi: 10.1093/hmg/ddw245. (pii: ddw245) [DOI] [PubMed] [Google Scholar]
  • 5.Riley L.G., Rudinger-Thirion J., Schmitz-Abe K., Thorburn D.R., Davis R.L., Teo J., Arbuckle S., Cooper S.T., Campagna D.R., Frugier M., Markianos K., Sue C.M., Fleming M.D., Christodoulou J. LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure. JIMD Rep. 2016;28:49–57. doi: 10.1007/8904_2015_515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Catteruccia M., Verrigni D., Martinelli D., Torraco A., Agovino T., Bonafé L., D'Amico A., Donati M.A., Adorisio R., Santorelli F.M., Carrozzo R., Bertini E., Dionisi-Vici C. Persistent pulmonary arterial hypertension in the newborn (PPHN): a frequent manifestation of TMEM70 defective patients. Mol Genet Metab. 2014 Mar;111(3):353–359. doi: 10.1016/j.ymgme.2014.01.001. [DOI] [PubMed] [Google Scholar]
  • 7.Danqun J., Jie D., Wenjia T., Kefei H. Clinical characteristics and genetic analysis of two cases with Leigh syndrome with acute pulmonary hemorrhage as predominant manifestation. Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):290–295. [PubMed] [Google Scholar]
  • 8.Amornvit J., Pasutharnchat N., Pachinburavan M., Jongpiputvanich S., Joyjinda Y. Fulminant respiratory muscle paralysis, an expanding clinical spectrum of mitochondrial A3243G tRNALeu mutation. J Med Assoc Thai. 2014 Apr;97(4):467–472. [PubMed] [Google Scholar]
  • 9.Yang C.C., Hwang C.C., Pang C.Y., Wei Y.H. Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNA(Leu(UUR))gene. J Formos Med Assoc. 1998 Oct;97(10):715–719. [PubMed] [Google Scholar]
  • 10.Shanske A.L., Shanske S., Silvestri G., Tanji K., Wertheim D., Lipper S. MELAS point mutation with unusual clinical presentation. Neuromuscul Disord. 1993 May;3(3):191–193. doi: 10.1016/0960-8966(93)90058-r. [DOI] [PubMed] [Google Scholar]
  • 11.Ramezani R.J., Stacpoole P.W. Sleep disorders associated with primary mitochondrial diseases. J Clin Sleep Med. 2014 Nov 15;10(11):1233–1239. doi: 10.5664/jcsm.4212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tan A.L., Goy R. Anaesthetic management of a patient with Leigh's syndrome with central hypoventilation and obstructive sleep apnoea. Singapore Med J. 2013 Dec;54(12):e250–253. doi: 10.11622/smedj.2013252. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Genetics and Metabolism Reports are provided here courtesy of Elsevier

RESOURCES